We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$13.9B
AUM Growth
+$146M
Cap. Flow
+$287M
Cap. Flow %
2.07%
Top 10 Hldgs %
11.54%
Holding
3,080
New
521
Increased
857
Reduced
739
Closed
172

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$44.4M
2
TXN icon
Texas Instruments
TXN
+$39.6M
3
CHD icon
Church & Dwight Co
CHD
+$39.1M
4
BA icon
Boeing
BA
+$34.3M
5
DIS icon
Walt Disney
DIS
+$34M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$47.1M
2
AMP icon
Ameriprise Financial
AMP
+$42.3M
3
NTAP icon
NetApp
NTAP
+$38.1M
4
SYK icon
Stryker
SYK
+$35.6M
5
BALL icon
Ball Corp
BALL
+$34.9M

Sector Composition

Rank Sector Weight
1 Technology 15.68%
2 Healthcare 14.66%
3 Industrials 11%
4 Financials 10.76%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTRN icon
751
Materion
MTRN
$4.87B
$766K 0.01%
21,745
+271
+1% +$10.4K
KEX icon
752
Kirby Corp
KEX
$7.71B
$762K 0.01%
9,950
NSR
753
DELISTED
Neustar Inc
NSR
$759K 0.01%
26,011
BF
754
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
$757K 0.01%
8,634
+51
+0.6% +$4.47K
OAK
755
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$752K 0.01%
14,150
ETP
756
DELISTED
Energy Transfer Partners, L.P.
ETP
$750K 0.01%
19,748
GOV
757
DELISTED
Government Properties Income Trust
GOV
$749K 0.01%
40,479
-67,159
-62% -$1.37M
AV
758
DELISTED
Aviva Plc
AV
$747K 0.01%
48,031
-61,772
-56% -$1M
CS
759
DELISTED
Credit Suisse Group
CS
$744K 0.01%
26,996
+26,694
+8,839% +$722K
MD icon
760
Pediatrix Medical
MD
$2.17B
$738K 0.01%
9,968
+1,264
+15% +$91K
HBP
761
DELISTED
Huttig Building Products, Inc.
HBP
$737K 0.01%
235,000
-25,000
-10% -$82.8K
GCI
762
DELISTED
Gannett Co., Inc
GCI
$735K 0.01%
+52,648
New +$750K
OKS
763
DELISTED
Oneok Partners LP
OKS
$733K 0.01%
21,600
-250
-1% -$9.89K
NTUS
764
DELISTED
Natus Medical Inc
NTUS
$732K 0.01%
17,235
+116
+0.7% +$4.62K
NMR icon
765
Nomura Holdings
NMR
$28.4B
$731K 0.01%
108,188
+45,293
+72% +$295K
PC
766
DELISTED
PANASONIC CORP ADR (REP 1 SHR COM STK) (JP)
PC
$729K 0.01%
53,183
+21,637
+69% +$297K
PBF icon
767
PBF Energy
PBF
$7.28B
$726K 0.01%
25,594
+334
+1% +$9.39K
PFS icon
768
Provident Financial Services
PFS
$3.12B
$722K 0.01%
38,078
-28,158
-43% -$521K
TI
769
DELISTED
Telecom Italia
TI
$722K 0.01%
+56,800
New +$697K
WM icon
770
Waste Management
WM
$96.3B
$719K 0.01%
15,532
+638
+4% +$32.1K
EEP
771
DELISTED
Enbridge Energy Partners
EEP
$718K 0.01%
21,563
CPLA
772
DELISTED
Capella Education Company
CPLA
$717K 0.01%
13,395
+677
+5% +$39.1K
CAG icon
773
Conagra Brands
CAG
$7.24B
$714K 0.01%
21,053
+43
+0.2% +$1.29K
DIA icon
774
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.4B
$711K 0.01%
4,047
-100
-2% -$18K
DY icon
775
Dycom Industries
DY
$12.4B
$705K 0.01%
12,000
+88
+0.7% +$4.66K

Similar funds

Glenmede Trust's Q2 2015 Portfolio in Review

As of Q2 2015, Glenmede Trust held 3,080 positions worth $13.9B, up 1.1% from $13.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Glenmede Trust's Q2 2015 filing shows 521 new, 857 increased, 739 reduced and 172 closed positions. Its largest new stake was Iridium Communications: 2,746,232 shares worth $25M. The largest sale was Oracle, an estimated $47.1M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Glenmede Trust's largest Q2 2015 buy was Iridium Communications: 2,746,232 shares worth $25M.
  • Glenmede Trust added most to Microsoft in Q2 2015, an estimated $44.4M increase.
  • Glenmede Trust's biggest Q2 2015 reduction was Oracle, cutting an estimated $47.1M.
  • Glenmede Trust fully exited Triumph Group in Q2 2015, selling an estimated $30M.
  • Glenmede Trust's ten largest holdings make up 12% of its $13.9B portfolio in Q2 2015.
  • Glenmede Trust opened 521 new positions and closed 172 in Q2 2015.
  • Glenmede Trust's portfolio value rose 1.1% quarter-over-quarter to $13.9B.

Based on Glenmede Trust's 13F filing for Q2 2015, filed 22 Jul 2015.